Quantcast

Latest Oncology Stories

2014-06-17 04:21:42

Proof-of-Concept Trial Targets DNA Repair in Bile Duct Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, June 17, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc. announced today that the Company has initiated a randomized Phase 1b/2 Trial of CX-4945 in combination with gemcitabine and cisplatin for the frontline treatment of patients with bile duct cancers (cholangiocarcinoma). This Proof-of-Concept trial will study the use of CX-4945, a small molecule CK2 inhibitor, to suppress...

2014-06-17 04:21:35

Expanded License Includes New Product Candidates for Cancer, Infectious Diseases and Novel Immune Activators BLUE BELL, Pa., June 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide rights to technology and intellectual property for novel synthetic therapies against cancer, infectious diseases and new immune activators. Inovio has an ongoing collaborative research...

2014-06-16 23:12:58

This week the Mesothelioma Victims Center tackles a side to mesothelioma never previously discussed by sharing a recent ACS article titled, “Nearing the End of Life.” The group is urging family members of a diagnosed victim of mesothelioma to read the article and then call them at 866-714-6466 not only for instant access to the nation's best mesothelioma compensation attorneys, but as importantly for information on how a family should deal with this rare, and lethal form of cancer....

2014-06-16 23:07:52

Tanning and sun exposure increases risk, but early detection is almost 100% effective. (PRWEB) June 16, 2014 We all enjoy having fun in the great outdoors. Whether someone is hiking, swimming horseback riding, or just having a picnic, the lure of a sunny day is hard to resist. Doctors have been telling people for years to wear sunscreen when they go outdoors, but the honest truth is that few people listen. The reason for this concern is of the lurking danger of melanoma, which is the most...

2014-06-16 23:01:53

Leaders will share best methods for addressing survivors’ needs. Austin, Texas (PRWEB) June 16, 2014 The LIVESTRONG Foundation is hosting its Survivorship Centers of Excellence Network as they present the LIVESTRONG Essential Elements of Survivorship Care to some of the leading providers of cancer care programs from throughout the U.S. in advance of this week’s 7th Biennial Cancer Survivorship Research Conference in Atlanta. Directors from the seven LIVESTRONG Survivorship Centers of...

2014-06-16 18:08:50

IASLC Examination and review of several studies that evaluated patient-centered outcomes for individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer found that screening does not appear to significantly influence overall health-related quality of life or result in long-term changes in anxiety or distress, but that positive results in the short-term, do increase distress levels. The National Lung Cancer Screening Trial showed that three annual LDCT screens,...

2014-06-16 16:25:14

Lung-MAP Trial Will Test Five Investigational Approaches, Including Amgen's Rilotumumab, an Investigational Fully Human Monoclonal Antibody THOUSAND OAKS, Calif., June 16, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) announced today that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP), a groundbreaking new clinical trial program that will use...

2014-06-16 12:28:47

CAMBRIDGE, Mass., June 16, 2014 /PRNewswire/ -- KEW Group Inc. (KEW), a privately held oncology services company located in Cambridge, Mass., announced today the appointment of Scott Schell, MD, MBA, PhD, as KEW's new President and Chief Executive Officer. KEW is focused on revolutionizing cancer care by empowering oncologists to access and apply genomic insights to design optimal, individualized treatment approaches for patients. Dr. Schell, who will also become a member of KEW's...

2014-06-16 08:28:29

Company continues to engage leading cancer treatment centers to investigate non-invasive methods of cancer mutation detection in order to advance patient care SAN DIEGO, June 16, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time...

2014-06-15 14:59:20

Broad Institute of MIT and Harvard Cellular makeup of glioblastoma more diverse than previously thought Scientists from the Broad Institute and Massachusetts General Hospital (MGH) have conducted a first-of-its-kind study that characterizes the cellular diversity within glioblastoma tumors from patients. The study, which looked at the expression of thousands of genes in individual cells from patient tumors, revealed that the cellular makeup of each tumor is more heterogeneous than...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.